SLB NV
SLB · NYSE
About SLB
- Employees
- 109,000
- Headquarters
- Houston, Texas
- Listed
- Feb 2, 1962
- Sector
- Energy
- Industry
- Energy Equipment & Services
- Website
- slb.com
SLB key statistics
- Market cap
- 72.86B
- Price-earnings ratio
- 23.72
- Dividend yield
- 2.32%
- Average volume
- 11.94M
- Volume
- 9.06M
- Open price
- $49.84
- High today
- $50.14
- Low today
- $49.07
- 52 Week high
- $60.46
- 52 Week low
- $31.64
SLB NV (SLB) at a glance
SLB NV (SLB) last traded at $49.98, with a market cap of 72.86B, a price-to-earnings ratio of 23.71 and a dividend yield of 2.32%.
Today the stock has traded between $49.07 and $50.14. The current price is 1.9% above the day's low and 0.3% below its high.
Volume so far is 9.06M shares, below the average of 11.94M shares a day.
Over the past year SLB NV has ranged from $31.64 to $60.46, and now sits 64% of the way up that range.
SLB NV met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.55 per share against an estimate of $0.5191.
The average analyst price target is $63.53, 27.1% above the current price, from 19 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy94.7%
- Hold0.0%
- Sell5.3%
- Low
- $43.43
- Now
- $49.98
- High
- $78.75
SLB earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 4 of the last 8 quarters, by 3.4% on average.
- Q3 FY99: reported $0.125 per share against an estimate of $0.1282
- Q4 FY99: reported $0.115 per share against an estimate of $0.1249
- Q1 FY00: reported $0.12 per share against an estimate of $0.1243
- Q2 FY00: reported $0.135 per share against an estimate of $0.1344
- Q3 FY00: reported $0.175 per share against an estimate of $0.17
- Q4 FY25: reported $0.78 per share against an estimate of $0.7482
- Q1 FY26: reported $0.52 per share against an estimate of $0.5211
- Q2 FY26: reported $0.55 per share against an estimate of $0.5191
SLB news
- Press releaseBusiness Wire
- Chandrima Sanyal
JPMorgan’s October Stock Picks Hint at 3 ETF Trades: Value, AI Power, Health Care
- Lekha Gupta
What's Going On With ExxonMobil Stock Tuesday?
- Press releaseBusiness Wire
SLB OneSubsea Awarded Major Subsea Systems Contract for Rovuma Basin Development
- Press releaseBusiness Wire
SLB Announces Date for Third-Quarter 2026 Results Conference Call
- Press releaseBusiness Wire
SLB Awarded Four Multi-Year Integrated Well Construction Contracts by Aramco
- Akanksha Bakshi
SLB Expands Oman Footprint with Bisat-B Facility Project
- Press releaseBusiness Wire
SLB Awarded Major Contract by OQEP for Integrated Facility Expansion in Oman
Similar companies
Companies in the same industry as SLB NV
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.